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Abstract
Background: Orexins are hypothalamic neuropeptides recently involved in the regulation of emotional memory. The basolateral 
amygdala, an area orchestrating fear memory processes, appears to be modulated by orexin transmission during fear extinction. 
However, the neuronal types within the basolateral amygdala involved in this modulation remain to be elucidated.
Methods: We used retrograde tracing combined with immunofluorescence techniques in mice to identify basolateral amygdala 
projection neurons and cell subpopulations in this brain region influenced by orexin transmission during contextual fear 
extinction consolidation.
Results: Treatment with the orexin-1 receptor antagonist SB334867 increased the activity of basolateral amygdala neurons 
projecting to infralimbic medial prefrontal cortex during fear extinction. GABAergic interneurons expressing calbindin, but 
not parvalbumin, were also activated by orexin-1 receptor antagonism in the basolateral amygdala.
Conclusions: These data identify neuronal circuits and cell populations of the amygdala associated with the facilitation of 
fear extinction consolidation induced by the orexin-1 receptor antagonist SB334867.
Keywords: fear extinction, orexin, amygdala, retrograde labeling, calbindin
Introduction
Orexins (also known as hypocretins) are hypothalamic neuropep-
tides that activate 2 different G-protein coupled receptors: orexin 
type 1 (OX1R) and 2 (OX2R) (de Lecea et al., 1998; Sakurai et al., 
1998). Orexin-expressing neurons are exclusively located in the lat-
eral hypothalamus, but they have extensive projections through-
out the brain (Peyron et al., 1998). The orexin system is involved 
in multiple physiological functions (Li et al., 2014), including the 
modulation of emotional memory (Flores et al., 2015).
Clinical research showed a reduced amygdala activity dur-
ing aversive conditioning in human narcolepsy (Ponz et  al., 
2010), a pathophysiological condition associated with a loss of 
orexin neurons (Peyron et al., 2000). Pharmacological blockade 
or genetic deletion of OX1R impaired contextual and cued fear 
conditioning (Sears et  al., 2013; Soya et  al., 2013; Flores et  al., 
2014; Wang et al., 2017) in rodents. Moreover, OX1R antagonism 
facilitated the consolidation of both contextual and cued fear 
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extinction (Flores et  al., 2014). Interestingly, in the contextual 
test, the extinction-facilitating effects of the OX1R antagonist 
SB334867 were associated with increased c-Fos expression in 
the basolateral amygdala (BLA), suggesting an involvement of 
this brain area (Flores et al., 2014). Local blockade of OX1R in the 
BLA mimicked the effects of systemic OX1R antagonist admin-
istration, further supporting the relevance of OX1R signalling 
within this brain structure during contextual fear extinction.
Several studies measuring immediate-early gene expression 
conclude that hypoactivity of specific brain areas of the cortico-
amygdala circuit, such as the infralimbic medial prefrontal 
cortex (IL) and the BLA, is related to impaired fear extinction 
(Holmes and Singewald, 2013). Furthermore, complete extinc-
tion of conditioned fear is associated with increased expression 
of markers for neuronal activation in these brain areas (Herry 
and Mons, 2004). Distinct populations of BLA neurons encode 
fear conditioning and extinction processes (Herry et al., 2008). 
These cell populations, functionally defined as “fear neurons” 
and “extinction neurons,” overlap with 2 different anatomically 
defined subtypes of BLA neurons projecting to prelimbic medial 
prefrontal cortex (PL) or IL, respectively (Senn et  al., 2014). 
Nonpyramidal GABAergic interneurons within the BLA can be 
classified by the content of several calcium-binding proteins 
such as calbindin (CB) and/or parvalbumin (PV) (McDonald and 
Mascagni, 2001; Capogna, 2014), which could differentially con-
trol these neuronal circuits since they are involved in fear and 
anxiety (Butler et al., 2011; Wolff et al., 2014). Whether orexins 
affect these circuits and GABAergic interneuron subpopulations 
during emotional memory processes remain unexplored.
In this study, we used retrograde tracing and immunofluo-
rescence techniques to identify cell subtypes within the BLA 




Male C57BL6/J mice (12 weeks old, Janvier) were individually 
housed for 7 days prior to experiments and provided with food 
and water ad libitum. Housing was maintained at constant tem-
perature (21 ± 1°C) and humidity (55 ± 10%) under a 12-h-light/-dark 
cycle, and all studies were performed during the light phase. All 
animal procedures were conducted in accordance with standard 
ethical guidelines (European Communities Directive 86/60-EEC) 
and were approved by the committee on Animal Health and Care 
of Institut National de la Santé et de la Recherche Médicale and 
French Ministry of Agriculture and Forestry (agreement A3312001).
Drugs
The OX1R antagonist SB334867 (5 mg/kg) (Tocris) was dissolved 
in 1% (wt/vol) 2-hydroxypropyl-βcyclodextrin (Sigma-Aldrich) 
and 10% dimethyl-sulfoxide (vol/vol) in distilled water, and 
administered by i.p. route (5 mL/kg).
Contextual Fear Extinction
Mice were fear conditioned in a shuttle chamber surrounded by a 
larger sound-attenuating cabinet (Imetronic). The shuttle cham-
ber floor was constructed of parallel stainless-steel bars and con-
nected to a scrambled shock generator. On the training day, mice 
were placed in the conditioning chamber for 3 minutes before the 
exposure to an unconditioned stimulus (US, 0.6-mA footshock for 
2s) and then remained in the chamber for 1 minute. Testing was 
performed during 2 extinction trials (E1 and E2 at 24 and 48 hours 
after the training, respectively) by scoring freezing behavior dur-
ing the first 3 minutes of a 5-minute exposure to the conditioning 
chamber. Freezing, a rodent’s natural response to fear (LeDoux, 
1993), was defined as the absence of movement and was scored 
by an automated infrared beam detection system located on the 
bottom of the experimental chambers (Imetronic). SB334867 or 
vehicle was administered immediately after the first extinction 
session (E1), targeting the consolidation phase of fear extinction.
Stereotaxic Surgery and Retrograde Labeling
We used fluorophore-coated latex microspheres (red excita-
tion = 530 nm, emission = 590 nm; and green excitation = 460 nm, 
emission = 505  nm) referred to as retrobeads (Lumafluor) for 
retrograde labeling of BLA neurons projecting to the PL or IL. 
Mice were anesthetized with isoflurane (induction 3%, main-
tenance 1.5%) in oxygen. Body temperature was maintained at 
37ºC with a temperature controller system. Mice were secured 
in a stereotaxic frame and injected unilaterally with differently 
colored retrobeads to the PL and IL using a syringe in combina-
tion with glass pipettes (borosilicate glass capillaries pulled on 
a micropipette puller P-97, Sutter Instruments). One-half of the 
animals were injected with red retrobeads in the PL and green 
in the IL, and the other one-half with the inverse combination, 
to avoid bead-induced bias in visualization and/or retrotracing. 
The injection volume for each region of the medial prefrontal 
cortex (mPFC) was 0.2 μL. Coordinates to target PL were: anter-
oposterior +1.80 mm, mediolateral ±0.25 mm, and dorsoventral 
–1.60 mm relative to bregma; IL was targeted in a 16° angle at: 
anteroposterior +1.80  mm, mediolateral ±0.95  mm, and dor-
soventral –2.70  mm relative to bregma. Injection micropipette 
was removed from the brain 20 minutes after each injection to 
minimize tracing outside the injection site. Mice were individu-
ally housed and allowed to recover for 4 weeks before behavioral 
training in order to grant substantial retrograde bead transport.
Immunofluorescence and Imaging
Tissue Preparation
Two hours after the second extinction trial (E2), retrobead-injected 
mice were transcardially perfused with 4% paraformaldehyde, 
postfixed in the same fixative for 24 hours (4°C), and cryoprotected 
in a solution of 30% sucrose at 4°C. Coronal frozen sections contain-
ing the BLA (from –1.22 mm to –1.82 mm relative to bregma) and 
the mPFC (from +1.98 mm to +1.54 mm relative to bregma) were 
made at 30 μm on a freezing microtome and stored in a 5% sucrose 
solution at 4°C until use. Slices containing the caudal and middle 
BLA regions were selected for immunofluorescence processing.
Injection Site Verification
Serial mPFC coronal sections were mounted onto glass slides. 
Low-magnification images from all slices showing retrobead 
presence were obtained using a Zeiss fluorescent microscope, 
and retrobead injection sites were histologically verified by over-
lapping to standard stereotaxic plates (Paxinos and Franklin, 
2001). Only animals with retrobead presence circumscribed into 
the PL or the IL were included in statistical analysis of c-Fos 
expression within retrolabeled neurons (12 of 23 mice).
Immunofluorescence
Free-floating BLA slices were rinsed in 0.1 M PB, blocked in a solu-
tion containing 3% normal goat serum and 0.3% Triton X-100 in 
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0.1M PB (NGS-T-PB) at room temperature for 2 hours, and incu-
bated overnight at 4ºC in the same solution with the primary anti-
body. Next day, after 3 rinses in 0.1 M PB, sections were incubated 
with the secondary antibody at room temperature in NGS-T-PB 
for 2 hours. After incubation, sections were rinsed and mounted 
immediately after onto glass slides coated with gelatine in 
Mowiol mounting medium. We used the following primary anti-
bodies: anti-c-Fos (1:500, rabbit, sc-72, Santa Cruz Biotechnology), 
anti-PV (1:500, guinea pig, Synaptic Systems), and anti-CB (1:500, 
mouse, Synaptic Systems). As secondary antibodies, we employed 
AlexaFluor-647 goat anti-rabbit (1:500, Life Technologies), 
AlexaFluor-555 goat anti-guinea pig (1:500, ThermoFisher), and 
AlexaFluor-488 goat anti-mouse (1:500, Jackson ImmunoResearch).
Image Analysis
Confocal images were obtained using a Leica TCS SP5 confo-
cal microscope (20× objective) (Leica Microsystems). Three-
dimensional z stacks were acquired using 3 different laser lines 
(488, 561, and 633nm), sectioned in 4-μm thin optical planes along 
16 to 20 μm (5–6 planes). Two-dimensional overview pictures (8 
bit, 1024 × 1024 pixels) were obtained by z projection and further 
analyzed in ImageJ software (6 sections per animal). Expression 
of c-Fos was determined bilaterally within the BLA using a fixed 
threshold interval (n = 11–12 mice/group). Colocalization of c-Fos 
with red or green retrobead positive neurons (n = 6 mice/group), 
as well as with PV or CB positive neurons (n = 9 mice/group), was 
quantified using the ImageJ manual particle counting option. PV 
and CB were analyzed unilaterally to avoid retrobead detection.
Statistical Analysis
Repeated-measures 2-way ANOVA was employed to analyze 
freezing behavior, followed by Fisher LSD posthoc test. Unpaired 
Student’s t test was used in histological experiments to compare 
vehicle- and SB334867-treated groups. The level of significance 
was P < 0.05 in all experiments.
Results
Treatment with the OX1R Antagonist SB334867 Is 
Associated with Increased Activity of BLA Neurons 
Projecting to IL during Fear Extinction
Mice were injected unilaterally into the PL and IL with 2 differ-
ent retrobeads coated with red or green fluorophores (Figure 1A 
and E) to assess whether orexin antagonism modifies the acti-
vation pattern of the putative fear (PL-projecting) and extinc-
tion (IL-projecting) neurons present in the BLA (Senn et al., 2014) 
during contextual fear extinction. After 4 weeks of recovery to 
allow sufficient axonal retrobead transport, mice underwent a 
contextual fear conditioning and extinction procedure. Freezing 
behavior was scored during the first extinction session (E1), mice 
were treated with SB334867 (5 mg/kg, i.p.) or vehicle immediately 
after, and 24 h later (second extinction session, E2) freezing was 
measured again (Figure 1A). As previously reported (Flores et al., 
2014), OX1R antagonism was able to modify the course of con-
textual fear extinction as shown by 2-way ANOVA (treatment 
x day: F(1,21) = 5.90; P < .05). Thus, SB334867-treated mice showed 
reduced levels of freezing at E2 compared with the vehicle 
group (P < .05) (Figure  1B), confirming the enhanced consolida-
tion of fear extinction due to OX1R blockade (Flores et al., 2014). 
Immunofluorescence processing of the BLA after E2 revealed an 
increase of c-Fos expression in SB334867-treated mice (P < .01) 
(Figure 1C–D). Successful retrograde labeling was then confirmed 
by red and green retrobead detection in different projection neu-
rons located within the BLA (Figure 1F), which resulted similarly in 
SB334867- and vehicle-treated groups (Figure 1G). Notably, analy-
sis of retrobead and c-Fos coexpression showed an increased 
activity of BLA neurons targeting the IL (P < .01) (Figure 1F) in mice 
injected with SB334867, suggesting that OX1R blockade facilitates 
the recruitment of these extinction-promoting projection neu-
rons. In contrast, no significant changes between groups were 
observed in the activity of PL-projecting neurons (Figure 1F). In 
addition, the number of nonretrolabeled c-Fos positive neurons 
in the BLA was higher in the SB334867 group than in the vehi-
cle-treated group (P < .01) (Figure  1H), suggesting that the OX1R 
antagonist is enhancing as well the activation of other neurons 
than those projecting to the IL (e.g., local interneurons). The total 
number of retrobead+, c-Fos+, and double-positive cells of each 
experimental condition is shown in supplementary Table 1.
OX1R Blockade Enhances the Activation of Local 
Interneurons Containing CB, but Not PV, within the 
BLA during Fear Extinction
To identify which other BLA neuronal populations are activated 
upon OX1R blockade during fear extinction, we investigated the 
2 most abundant groups of local interneurons within this brain 
area: those containing the calcium-binding proteins PV and CB. 
These cell subpopulations are mainly nonpyramidal GABAergic 
interneurons (McDonald and Mascagni, 2001) and are involved in 
fear and anxiety processes (Butler et al., 2011; Wolff et al., 2014). In 
agreement with previous studies, approximately 80% of PV neu-
rons exhibited colocalization with CB, and the number of neu-
rons expressing PV and/or CB was not modified in mice treated 
with the OX1R antagonist (Figure 2A). Interestingly, mice treated 
with SB334867 displayed higher expression of c-Fos within those 
nonpyramidal neurons containing CB only compared with con-
trol animals (P < .01) (Figure 2B). This effect was not observed in 
either the neuronal population expressing PV or both PV and CB 
(Figure 2B). The total number of CB+, PV+, and c-Fos+ cells, and 
double-/triple-stained cells for each experimental condition is 
shown in supplementary Table 2. Other projection cells or inhibi-
tory interneurons within the BLA could likewise be activated due 
to orexin antagonism during fear extinction, since c-Fos expres-
sion also increased in neurons that do not express CB or PV in 
SB334867-treated mice (P < .01) (supplementary Table 2).
Discussion
Our results identify specific neuronal subpopulations within the 
BLA associated with enhanced consolidation of fear extinction 
induced by OX1R blockade. Thus, the OX1R antagonist SB334867 
increased the recruitment of BLA projection neurons target-
ing the IL during the ensuing fear extinction trial. Moreover, 
GABAergic interneurons related to fear modulation that express 
the calcium-binding protein CB, but not PV, were activated by 
OX1R antagonism during this process.
Several recent reports have revealed a role for the orexin 
system in the regulation of emotional memories (Flores et al., 
2015). OX1R blockade facilitates the consolidation of fear 
extinction (Flores et  al., 2014), suggesting a potential useful-
ness of OX1R antagonists for the treatment of anxiety disorders 
associated with fear deregulation, such as phobias or post-
traumatic stress disorder. In agreement, the activation level 
of hypothalamic orexin neurons appears to be negatively cor-
related with successful extinction of cue-conditioned fear in 
rodents (Sharko et al., 2016). The BLA is a pivotal brain region 
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for processing fear, and decreased activity of this structure 
has been linked to impairment of fear extinction (Holmes 
and Singewald, 2013). Accordingly, the extinction-facilitating 
effects of the OX1R antagonist SB334867 were associated with 
increased c-Fos expression in the BLA, as previously reported 
(Flores et al., 2014).
The BLA and the mPFC are interconnected brain structures 
involved in the acquisition and extinction of conditioned fear 
(Dejean et al., 2015). The IL subdivision of the mPFC plays a cru-
cial role in extinction memory consolidation, while the adjacent 
PL subdivision has been implicated in sustained fear expres-
sion and resistance to extinction (Sierra-Mercado et  al., 2011). 
Figure 1. OX1R antagonism is associated with increased activity of basolateral amygdala (BLA) neurons projecting to infralimbic medial prefrontal cortex (IL) during 
fear extinction. A, Experimental design. Animals were injected with differently colored retrobeads into the prelimbic medial prefrontal cortex (PL) and IL. After 4 weeks 
of recovery to allow successful retrograde labelling, mice underwent contextual fear conditioning (FC), and freezing behavior was scored 24 hours later during contex-
tual reexposure (extinction session 1, E1). Immediately after E1, mice were treated with the OX1R antagonist SB334867 (SB, 5 mg/kg, i.p.) or vehicle (VEH), and freezing 
behavior was measured again 24 hours later (extinction session 2, E2). Animals were sacrificed for histochemical analysis 2 hours after E2. B, Time spent freezing by 
VEH- and SB-treated mice during E1 and E2 (n = 12–13 mice/group). C, Diagram showing anatomic location of BLA analyzed images. D, Number of c-Fos+ neurons within 
the BLA in VEH- and SB-treated mice after the E2 session (n = 12–13 mice/group; left panel). Representative images of c-Fos immunofluorescence (purple) in the BLA 
obtained by confocal microscopy are also shown (right panel). E, Diagram displaying injection sites within the medial prefrontal cortex (mPFC) of those mice suitable for 
histochemical analysis: upper panel shows overlaid fluorescence detected in 3 VEH- and 2 SB-treated mice, whereas lower panel corresponds to 3 VEH- and 4 SB-treated 
mice. F, Percentage of PL- and IL-projecting neurons per slice expressing c-Fos in mice receiving VEH or SB (left panel; n = 6 mice/group). Representative images of c-Fos 
(purple) and retrobead (red and green) colocalization at low and high magnification are also shown (right panel). G, Total number of retrolabelled neurons per slice 
projecting to PL and IL (n = 6 mice/group). H, Number of c-Fos+ nonretrolabelled neurons per slice (n = 6 mice/group). RB, retrobeads. Scale bars represent 200 µm in 
whole BLA pictures and 20 µm in high magnification pictures. *P < .05, **P < .01 between treatments.
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Recently, an elegant study using retrograde tracing and optoge-
netic approaches has revealed the existence of distinct subpopu-
lations of BLA projection neurons to the mPFC in fear expression 
and extinction (Senn et al., 2014). BLA neurons projecting to PL 
are active during high states of fear, whereas BLA neurons tar-
geting the IL are recruited during fear extinction (Senn et  al., 
2014). Notably, we observed an enhancement in the activation of 
BLA neurons projecting to IL, but not to PL, in mice treated with 
SB334867 during fear extinction. In agreement, OX1R antagonism 
has been reported to increase IL activation during this behavioral 
response (Flores et al., 2014). These results suggest that the facili-
tation of fear extinction consolidation induced by OX1R antago-
nism is associated with the recruitment of this BLA-IL neuronal 
circuit.
Figure 2. OX1R antagonism increases c-Fos expression in calbindin (CB)+ neurons within the basolateral amygdala (BLA) during fear extinction. A, Total number of CB+ 
neurons, parvalbumin (PV)+ neurons, and coexpressing CB+ PV+ neurons per slice detected within the BLA (n = 9 mice/group). Representative images showing CB+ 
(green), PV+ (red), and CB+PV+ (yellow) immunofluorescence is also displayed (lower panels). B, Percentage of c-Fos+ neurons among those expressing only CB, only PV, 
or coexpressing CB and PV. Representative images showing c-Fos (purple) expression within CB+ (green) neurons is also displayed (lower panels). Arrows indicate CB+ 
neurons expressing c-Fos. Scale bars represent 200 µm. **P < .01 between treatments.
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Nonpyramidal GABAergic interneurons within the BLA can 
be divided considering the content of several calcium-binding 
proteins such as CB and/or PV (McDonald and Mascagni, 2001). 
These cell subtypes have been previously involved in the regu-
lation of fear behaviors (Butler et al., 2011; Wolff et al., 2014) and 
could differentially modulate neuronal circuits related to fear 
conditioning and extinction processes. The administration of 
SB334867 increased the activation of neurons containing CB, but 
not PV, during the extinction of fear. In agreement, activation of 
CB-expressing interneurons appears to be inversely correlated 
with fear expression (Butler et al., 2014). Thus, rats exposed to 
predator odor displayed increased fear responses and reduced 
c-Fos expression in CB+ neurons in the BLA (Butler et al., 2011). 
PV neurons were not affected by the exposition to the same 
predator threat (Butler et  al., 2011). Together, these data sug-
gest that declined fear expression during the extinction process 
induced by OX1R antagonism could be due to the activation 
of local BLA interneurons expressing CB. Nevertheless, intra-
amygdalar microcircuits are still poorly understood, and hence 
it remains to be elucidated whether this increased activity of 
CB-expressing interneurons by OX1R blockade is related to the 
modulation of the BLA-IL circuit.
In conclusion, these data enhance our knowledge of the 
amygdala circuitry involved in the facilitation of fear extinction 
induced by OX1R antagonism. Such understanding will contrib-
ute to refine future therapeutic approaches for anxiety disorders 
characterized by pathological fear.
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